Indegene Limited share price

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, North America, and internationally. It operates through Enterprise Medical Solutions, Enterprise Commercial Solutions, and Other segments. The company provides AI-embedded commercialization services for biopharmaceutical, emerging biotech, and medical devices companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms, as well as provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizat…Read more

Website NSE BSE

HealthcareHealth Information ServicesNifty Microcap 250NSE: INDGNISIN INE065X01017

16 Oct 2026, 3:30 PM IST₹598.30▲ 7.10 (1.20%)

Market Cap₹ 14,409 Cr.
Current Price₹ 598.30
High / Low₹ 627 / 414
Stock P/E36.0
Book Value₹ 130
Dividend Yield0.38 %
ROCE15.3 %
ROE13.90 %
Face Value₹ 2.0

More figures (10)

EPS (TTM)₹ 16.60
Price / Book4.59
OPM14.2 %
Debt / Equity0.05
Sales growth (4Y)15.0 %
Profit growth (4Y)14.7 %
Promoter holding55.5 %
EV / EBITDA22.1
Beta0.75
All-time high₹ 736

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
INDGN	+4.38%	+17.10%	+22.31%	+14.96%	+10.83%	—	—
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

Indegene Limited is in the Health Information Services industry (Healthcare), with a market value of ₹14,409 crore.
It trades at 36.0 times its last 12 months' earnings and 4.6 times book value.
Revenue grew 15.0% a year over the last 4 years, profit 14.7% a year.
Return on equity was 13.9% and return on capital employed 15.3% in the latest year.
Debt was 0.05 times shareholders' equity.
The share price is 4.6% below its 52-week high and up 10.8% over one year.
Promoters and insiders hold about 55.5%; institutions about 26.9%.

Pros

Strong return on equity: 20.3% on average over the last 3 years.
Company is almost debt-free (debt is 0.05 times equity).
Institutional (FII + DII) holding has risen by 11.0 points over 9 quarters.

Cons

No standout weaknesses in the reported figures.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About Indegene Limited

Employees: 4,687
Head office: Bengaluru
NSE industry: Healthcare

Peer comparison

Company	Market cap (₹ Cr)	P/E	P/B	ROE	OPM	Sales CAGR	Div. yield
Indegene LimitedINDGN	14,409	36.0	4.59	13.9%	14.2%	+15.0%	0.38%
Sun Pharmaceutical Industries LimitedSUNPHARMA	4,21,995	34.9	5.05	14.7%	23.4%	+10.4%	0.91%
Divi's Laboratories LimitedDIVISLAB	2,42,758	83.0	14.48	16.2%	28.4%	+11.0%	0.33%
Torrent Pharmaceuticals LimitedTORNTPHARM	1,73,406	72.8	18.39	27.1%	25.0%	+13.3%	0.83%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP	1,13,446	54.3	11.97	21.9%	11.7%	+14.8%	0.25%
Zydus Lifesciences LimitedZYDUSLIFE	1,12,020	25.0	4.17	19.7%	21.7%	+16.5%	0.09%
Cipla LimitedCIPLA	1,07,051	31.8	3.11	11.8%	17.5%	+7.2%	0.98%
Dr. Reddy's Laboratories LimitedDRREDDY	1,02,707	31.0	2.68	12.1%	14.9%	+11.0%	0.66%
Max Healthcare Institute LimitedMAXHEALTH	82,342	56.7	7.66	14.3%	22.8%	+22.4%	0.23%
Abbott India LimitedABBOTINDIA	55,609	34.4	11.65	34.5%	26.3%	+9.0%	2.01%

Companies in the same industry (Health Information Services). Tap a heading to sort. Sorting is a way to explore data, not a recommendation.

Quarterly Results

Consolidated figures in ₹ crore /

₹ Cr	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	673	677	687	720	756	761	804	942	1,003	1,063
YOY Sales Growth %					12.27%	12.46%	17.09%	30.77%	32.80%	39.73%
	534	548	561	589	608	606	664	783	840	889
Employee Cost %	64%	66%	64%	62%	64%	63%	64%	60%	63%	62%
Other Expenses %	16%	15%	17%	20%	16%	16%	18%	23%	21%	22%
Operating Profit	139	129	126	132	148	155	141	160	164	174
OPM %	21%	19%	18%	18%	20%	20%	17%	17%	16%	16%
	23	23	21	38	26	22	20	19	11	29
Exceptional items	2								-20
Interest	12	12	4	3	3	4	4	5	7	6
Depreciation	19	20	19	20	21	22	23	40	42	44
Profit before tax	134	120	124	146	149	152	133	135	105	153
	29%	27%	26%	25%	21%	23%	23%	24%	24%	24%
Current tax	13	35	36	34	44	28	38	87	23	29
Deferred tax	26	-3	-4	3	-12	7	-7	-56	3	7
	95	88	92	110	118	116	102	103	80	116
Profit to shareholders	97	88	92	110		116		103	80	116
YOY Profit Growth %					24.05%	32.73%	11.34%	-6.20%	-32.23%	-0.17%
EPS in Rs	4.27	3.79	3.84	4.59	4.91	4.86	4.26	4.29	3.32	4.84
Raw filing

₹ Cr	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	273	259	282	287	267	256	307	290	368	341
YOY Sales Growth %					-2.13%	-1.16%	8.87%	1.19%	38.06%	33.29%
	226	219	235	235	227	219	236	252	265	281
Employee Cost %	72%	72%	70%	67%	69%	71%	65%	70%	58%	65%
Other Expenses %	11%	13%	14%	15%	16%	15%	12%	17%	14%	17%
Operating Profit	46	40	46	52	40	37	71	38	103	60
OPM %	17%	15%	16%	18%	15%	14%	23%	13%	28%	18%
Other Income	23	14	22	22	35	32	18	23	6	34
Interest	2	2	2	2	2	2	2	2	3	3
Depreciation	8	7	6	7	7	7	9	10	11	11
Profit before tax	60	45	61	66	66	60	78	49	95	80
	19%	28%	27%	25%	18%	25%	23%	29%	24%	25%
Current tax	12	12	17	17	17	15	17	13	26	18
Deferred tax	-1	1	-1	-1	-5	0	0	1	-3	2
	49	33	45	50	54	45	60	35	72	60
YOY Profit Growth %					10.84%	38.34%	33.71%	-30.26%	33.03%	32.82%
EPS in Rs	2.20	1.41	1.88	2.09	2.26	1.88	2.50	1.45	3.00	2.49
Raw filing

Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Consolidated figures in ₹ crore /

₹ Cr	Mar 2024	Mar 2025	Mar 2026	TTM
	2,590	2,839	3,511	3,813
YOY Sales Growth %		9.64%	23.64%
	2,084	2,305	2,892	3,175
Employee Cost %	64%	64%	63%	62%
Other Expenses %	17%	17%	20%	21%
Operating Profit	505	534	619	638
OPM %	20%	19%	18%	17%
	76	107	72	79
Exceptional items	2		-20	-20
Interest	49	22	19	22
Depreciation	76	80	126	149
Profit before tax	459	539	525	526
	27%	25%	24%	24%
Current tax	126	149	176
Deferred tax	-4	-17	-52
	337	407	401	401
Profit to shareholders	345		401	299
YOY Profit Growth %		20.79%	-1.38%
EPS in Rs	15.19	17.15	16.72	16.71
Dividend Payout %			12%

Compounded Sales Growth

TTM:: 30%

Compounded Profit Growth

TTM:: -8%

Stock Price CAGR

1 Year:: 11%

Return on Equity

4 Years:: 22%
Last Year:: 14%

₹ Cr	Mar 2024	Mar 2025	Mar 2026	TTM
	1,046	1,094	1,221	1,306
YOY Sales Growth %		4.59%	11.61%
	878	913	973	1,034
Employee Cost %	72%	69%	65%	64%
Other Expenses %	12%	14%	15%	15%
Operating Profit	168	181	248	272
OPM %	16%	17%	20%	21%
Other Income	50	90	78	80
Interest	7	6	9	10
Depreciation	31	26	36	40
Profit before tax	181	239	281	302
	24%	24%	25%	25%
Current tax	44	63	71
Deferred tax	-2	-6	-1
	138	181	212	227
YOY Profit Growth %		31.47%	16.88%
EPS in Rs	6.22	7.64	8.83	9.44
Dividend Payout %			23%

Compounded Sales Growth

TTM:: 20%

Compounded Profit Growth

TTM:: 17%

Stock Price CAGR

1 Year:: 11%

Return on Equity

4 Years:: 22%
Last Year:: 14%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	44	44	48	48
Reserves	1,019	1,385	2,568	3,091
	503	490	102	144
Long term borrowings	394	333
Short term borrowings		70
	638	627	609	1,337
Trade payables	73	118	93	181
Current liabilities	489	611	565	1,086
Total Liabilities	2,204	2,546	3,326	4,620
	152	121	139	206
Gross block	305	303	139	454
Accumulated depreciation	153			248
Goodwill & intangibles	519	531	543	1,618
CWIP	6		4	12
	2,046	2,425	3,184	4,403
Trade receivables	520	556	632	770
Cash & equivalents	74	189	241	301
Current assets	1,449	1,791	2,530	2,618
Total Assets	2,204	2,546	3,326	4,620

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	130	508	442	651
Profit for the year	266	337	407	401
Working capital changes	-216	96	24	146
Direct taxes paid	-108	-125	-160	-148
	-893	-327	-683	-512
Fixed assets purchased	-19	-11	-30	-44
Investments purchased	-500	-1,705	-7,074	-3,928
Investments sold	11	1,534	6,484	4,171
	333	-66	288	-83
Proceeds from borrowings	394
Repayment of borrowings	-18	-7	-403
Interest paid	-18	-32	-10
Dividends paid				-48
Net Cash Flow	-430	114	47	56
Free Cash Flow	111	497	412	606

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	—	25.0%	27.0%	20.1%	13.9%
ROCE	—	23.0%	26.1%	20.2%	15.3%
Operating margin	—	14.6%	16.8%	16.0%	14.2%
Net margin	—	11.5%	13.0%	14.3%	11.4%
Debt / equity	—	0.47	0.34	0.04	0.05
Current ratio	—	2.96	2.93	4.48	2.41

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities).

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

FIIs 9.91%
DIIs 8.74%
Public 81.34%

%	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	3.79%	4.82%	5.03%	5.24%	10.05%	11.30%	11.48%	10.27%	9.91%
Foreign portfolio investors (Cat. I)	3.66%	4.72%	4.83%	5.03%	9.69%	10.84%	11.22%	10.11%	9.71%
Foreign portfolio investors (Cat. II)	0.13%	0.10%	0.20%	0.21%	0.35%	0.46%	0.26%	0.16%	0.21%
	3.84%	3.17%	3.98%	4.96%	7.20%	6.96%	8.07%	8.30%	8.74%
Mutual funds	2.31%	1.64%	1.64%	2.65%	3.37%	3.07%	4.40%	4.70%	5.28%
Insurance companies	0.27%	0.11%	0.10%	0.04%	0.01%	0.01%	0.01%	0.01%	0.02%
Banks	0.02%	0.02%
Alternative investment funds	1.24%	1.40%	2.24%	2.27%	3.82%	3.87%	3.65%	3.58%	3.44%
	92.37%	92.01%	90.99%	89.80%	82.75%	81.74%	80.45%	81.44%	81.34%
Retail (up to ₹2 lakh)	5.94%	5.50%	8.39%	7.68%	9.69%	9.65%	8.83%	8.45%	8.35%
HNIs (above ₹2 lakh)	18.73%	18.82%	18.02%	3.66%	3.82%	3.63%	3.62%	4.11%	4.14%
NRIs	11.40%	11.50%	11.67%	4.54%	4.60%	4.60%	4.56%	4.63%	4.60%
Bodies corporate	3.98%	4.05%	4.59%	4.24%	6.07%	5.23%	4.99%	5.87%	5.95%
No. of Shareholders	2,03,599	1,51,440	1,53,789	1,44,708	1,51,997	1,51,809	1,47,182	1,42,119	1,38,533

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

None filed recently.

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Ex-dividend date: 31 Jul 2026
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Questions about Indegene Limited

What is the share price of Indegene Limited today?

Indegene Limited (INDGN) last traded at ₹598.30 on NSE (16 Oct 2026, 3:30 PM IST). Prices may be delayed.

What is the market cap of Indegene Limited?

About ₹14,409 crore at the latest price.

What is the P/E ratio of Indegene Limited?

About 36.0 times its earnings over the last 12 months.

Is Indegene Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy Indegene Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.

Indegene Limited share price

Price chart

Quick take

Pros

Cons

AI analysis

About Indegene Limited

Peer comparison

Quarterly Results

Profit & Loss

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings

Concalls & investor meets

Key dates

Trade with our broking desk

Questions about Indegene Limited

Have a question about this topic?

Book your free wealth consultation

Request received!

What happens next